Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.

Published in:

2015

By:

• Despierre, Evelyn;
• Vergote, Ignace;
• Anderson, Ryan;
• Coens, Corneel;
• Katsaros, Dionyssios;
• Hirsch, Fred;
• Boeckx, Bram;
• Varella-Garcia, Marileila;
• Ferrero, Annamaria;
• Ray-Coquard, Isabelle;
• Berns, Els;
• Casado, Antonio;
• Lambrechts, Diether;
• Jimeno, Antonio;
• Hirsch, Fred R;
• Berns, Els M J J;
• European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG), Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO);
• European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG);
• Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO);
• Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (A-AGO)

Publication type:

journal article